Martine Rothblatt
2012
In 2012, Martine Rothblatt earned a total compensation of $8M as Chairman and Co, Chief Executive Officer at United Therapeutics, a 152% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $2,964,410 |
|---|---|
| Non-Equity Incentive Plan | $983,362 |
| Option Awards | $3,024,662 |
| Salary | $959,579 |
| Other | $26,315 |
| Total | $7,958,328 |
Rothblatt received $3M in option awards, accounting for 38% of the total pay in 2012.
Rothblatt also received $3M of change in pension value and nonqualified deferred compensation earnings, $983.4K in non-equity incentive plan, $959.6K in salary and $26.3K in other compensation.
Rankings
In 2012, Martine Rothblatt's compensation ranked 616th out of 11,487 executives tracked by ExecPay. In other words, Rothblatt earned more than 94.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 616 out of 11,487 | 95th |
Division Manufacturing | 221 out of 4,253 | 95th |
Major group Chemicals And Allied Products | 49 out of 1,198 | 96th |
Industry group Drugs | 26 out of 920 | 97th |
Industry Pharmaceutical Preparations | 23 out of 700 | 97th |
Source: SEC filing on April 30, 2015.
Rothblatt's colleagues
We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2012.